Takakura Y - Search Results

1

[In vivo siRNA delivery to tumor cells and its application to cancer gene therapy].

Takahashi Y, Nishikawa M, Takakura Y. Takahashi Y, et al. Among authors: takakura y. Yakugaku Zasshi. 2007 Oct;127(10):1525-31. doi: 10.1248/yakushi.127.1525. Yakugaku Zasshi. 2007. PMID: 17917414 Free article. Review. Japanese.

2

Demonstration of the receptor-mediated hepatic uptake of dextran in mice.

Nishikawa M, Yamashita F, Takakura Y, Hashida M, Sezaki H. Nishikawa M, et al. Among authors: takakura y. J Pharm Pharmacol. 1992 May;44(5):396-401. doi: 10.1111/j.2042-7158.1992.tb03632.x. J Pharm Pharmacol. 1992. PMID: 1279155

3

Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion.

Fujita T, Furitsu H, Nishikawa M, Takakura Y, Sezaki H, Hashida M. Fujita T, et al. Among authors: takakura y. Biochem Biophys Res Commun. 1992 Nov 30;189(1):191-6. doi: 10.1016/0006-291x(92)91543-y. Biochem Biophys Res Commun. 1992. PMID: 1449473

4

Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives.

Fujita T, Nishikawa M, Tamaki C, Takakura Y, Hashida M, Sezaki H. Fujita T, et al. Among authors: takakura y. J Pharmacol Exp Ther. 1992 Dec;263(3):971-8. J Pharmacol Exp Ther. 1992. PMID: 1469654

5

Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting.

Nishikawa M, Kamijo A, Fujita T, Takakura Y, Sezaki H, Hashida M. Nishikawa M, et al. Among authors: takakura y. Pharm Res. 1993 Sep;10(9):1253-61. doi: 10.1023/a:1018949109004. Pharm Res. 1993. PMID: 7694271

6

Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties.

Nishikawa M, Miyazaki C, Yamashita F, Takakura Y, Hashida M. Nishikawa M, et al. Among authors: takakura y. Am J Physiol. 1995 May;268(5 Pt 1):G849-56. doi: 10.1152/ajpgi.1995.268.5.G849. Am J Physiol. 1995. PMID: 7762669

7

Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency.

Nishikawa M, Hirabayashi H, Takakura Y, Hashida M. Nishikawa M, et al. Among authors: takakura y. Pharm Res. 1995 Feb;12(2):209-14. doi: 10.1023/a:1016222808484. Pharm Res. 1995. PMID: 7784335

8

Control of in vivo fate of albumin derivatives utilizing combined chemical modification.

Fujita T, Nishikawa M, Ohtsubo Y, Ohno J, Takakura Y, Sezaki H, Hashida M. Fujita T, et al. Among authors: takakura y. J Drug Target. 1994;2(2):157-65. doi: 10.3109/10611869409015905. J Drug Target. 1994. PMID: 8069594

9

Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediated mechanism.

Takakura Y, Masuda S, Tokuda H, Nishikawa M, Hashida M. Takakura Y, et al. Biochem Pharmacol. 1994 Mar 2;47(5):853-8. doi: 10.1016/0006-2952(94)90485-5. Biochem Pharmacol. 1994. PMID: 8135860

10

Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.

Hirabayashi H, Nishikawa M, Takakura Y, Hashida M. Hirabayashi H, et al. Among authors: takakura y. Pharm Res. 1996 Jun;13(6):880-4. doi: 10.1023/a:1016053128569. Pharm Res. 1996. PMID: 8792426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

809 results

Search Page

Filters